CG
LH icon

Caprock Group’s Labcorp LH Stock Holding History

Caprock Group’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$656K Sell
2,344
-488
-17% -$128K 0.01% 768
2026
Q1 		$756K Sell
2,832
-894
-24% -$242K 0.02% 622
2025
Q4 		$935K Sell
3,726
-31
-0.8% -$8.23K 0.02% 621
2025
Q3 		$1.05M Buy
+3,757
New +$1.01M 0.03% 558
2025
Q1 		$510K Sell
2,189
-3,205
-59% -$778K 0.02% 706
2024
Q4 		$1.24M Buy
5,394
+1,244
+30% +$285K 0.04% 372
2024
Q3 		$927K Sell
4,150
-35
-0.8% -$7.69K 0.03% 408
2024
Q2 		$852K Buy
4,185
+1,034
+33% +$210K 0.03% 411
2024
Q1 		$688K Buy
3,151
+67
+2% +$14.8K 0.04% 327
2023
Q4 		$701K Buy
3,084
+56
+2% +$11.8K 0.04% 304
2023
Q3 		$609K Buy
3,028
+210
+7% +$44.3K 0.05% 320
2023
Q2 		$584K Sell
2,818
-144
-5% -$27.9K 0.04% 336
2023
Q1 		$584K Buy
+2,962
New +$610K 0.05% 326
2016
Q4 		– Sell
-1,797
Closed -$212K – 368
2016
Q3 		$212K Buy
+1,797
New +$212K 0.05% 320

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Caprock Group's LH Position: Q2 2026 in Review

Caprock Group reduced its Labcorp (LH) stake by 17% in Q2 2026, selling an estimated $128K and leaving 2,344 shares worth $656K. The position accounts for 0.01% of the portfolio, ranked #768.

Caprock Group first reported a position in LH in Q3 2016 and has held it in 14 quarters since. The position peaked at $1.24M in Q4 2024. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Caprock Group held 2,344 shares of Labcorp worth $656K as of Q2 2026.
  • Caprock Group sold 488 Labcorp shares in Q2 2026, an estimated $128K.
  • Labcorp made up 0.01% of Caprock Group's portfolio in Q2 2026, its #768 holding.
  • Caprock Group first reported a position in Labcorp in Q3 2016 and has held it in 14 quarters since.
  • Caprock Group's Labcorp position peaked at $1.24M in Q4 2024.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.